The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib trial of cabozantinib in combination with durvalumab (MEDI4736) in previously treated patients with advanced gastroesophageal cancer and other gastrointestinal (GI) malignancies (CAMILLA).
 
Anwaar Saeed
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Lilly
 
Devin Koestler
No Relationships to Disclose
 
Stephen K. Williamson
Research Funding - Acceleron Pharma (Inst); Aleon Pharma (Inst); Astellas Pharma (Inst); Bayer Health (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Merck Serono (Inst); Nektar (Inst); Novartis (Inst); Pharmacyclics (Inst); Regeneron (Inst); Rogosin Institute (Inst); Sanofi (Inst); Seagen (Inst); Sotio (Inst)
 
Joaquina Celebre Baranda
Employment - Halozyme
Stock and Other Ownership Interests - Adaptimmune; Halozyme; Ignyta; Loxo
Research Funding - Novartis
 
Weijing Sun
Honoraria - Genentech/Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer
Research Funding - Bayer; Merck (Inst)
 
Raed Moh'd Taiseer Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - Amgen
Research Funding - EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Anup Kasi
Research Funding - Halozyme
 
Mazin Francis Al-Kasspooles
No Relationships to Disclose
 
Dharmalingam Subramaniam
No Relationships to Disclose
 
Shrikant Anant
No Relationships to Disclose